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Abstract
Objective: MMP-13 performs digestion of collagen, which is a primary component of the
temporomandibular joint (TMJ) articular disc. This study evaluated the expression of MMP-13
in patients with anterior disc displacement with (ADDwR) and without reduction (ADDwoR),
and in the presence of TMJ osteoarthrosis.
Methods: Thirty-nine human temporomandibular joint disc samples were collected and divided
in two ways: ADDwR (21 samples), ADDwoR (10 samples), and a control group (8 samples);
and with osteoarthrosis (10 samples) and without osteoarthrosis (29 samples). Immunostaining
of the TMJ discs was statistically compared between the groups.
Results: There was no statistically significant difference for the area of MMP-13
immunostaining between the control group, ADDwR, and ADDwoR, nor between groups with
and without osteoarthrosis.
Conclusion: This study suggests MMP-13 is not significantly involved in collagen degradation
in human TMJ disc displacement or osteoarthrosis.

Keywords: Temporomandibular disorder, disc derangement, osteoarthrosis
Introduction
Temporomandibular joint derangement (TMD) is a common disease that affects many people
around the world, with a major prevalence in females [1–4]. The most commonly found disorder
in the temporomandibular joint (TMJ) is the abnormal positioning of the articular disc [1,5–8]. The
two most frequent types of disc displacement are anterior disc displacement with (ADDwR)
and without reduction (ADDwoR). In ADDwR, the disc returns to its normal position during
mouth opening, and it goes back to its displaced position when the mouth closes completely,
which is clinically represented by an articular click. Hence, in ADDwoR, the disc is unable to
return to its normal position, which leads to a decrease in mouth opening and is usually painful
[9,10].
The disc displacement may contribute to the progression of TMJ derangement and could lead
to osteoarthrosis of the TMJ, which is characterized by the abnormal remodeling of osseous
structures of the joint, frequently accompanied by pain, limiting functional capability [11–14].
Previous studies have shown that alteration of the disc structure may impact the expression of
some mediators related to apoptosis and inflammatory process, and they could be associated
with TMD progression [15–26]. The articular disc of the TMJ is formed basically by proteoglycan
aggregates and collagen fibers that are composed mainly of type 1 and 2 collagen; its
physiologic maintenance is through a balance between degradation of collagen fibers
performed by matrix metalloproteinase (MMP) and their inhibitors, tissue inhibitor of matrix
metalloproteinase (TIMP) [26–28].

In this study, the hypothesis was that MMP-13 might be involved in the progression of TMD.
Therefore, the present investigation was designed to evaluate, through immunohistochemistry,
the expression of MMP-13 in TMJ articular discs of ADDwR and ADDwoR patients. Moreover,
the presence of TMJ osteoarthrosis was also investigated to better understand the relationship
between TMD advanced stages and MMP-13 expression.

Materials and methods
Sample selection
A sample of 39 temporomandibular joint discs was collected from 27 patients, with a mean age
of 33.59 years old (17 to 57 years), for study at the Evangelico School Hospital, Curitiba, in the
Southern region of Brazil (Table 1). This study was approved by the Ethical Committee on
Research at Pontifical Catholic University of Paraná, according to Resolution 196/96 of the
National Health Council and approved under registration number 104. Subjects were not
included in the study if presenting: use of orthodontic appliances, chronic usage of antiinflammatory drugs, history of diabetes, hepatitis, HIV infection, immunosuppressive
chemotherapy, history of any disease known to severely compromise immune function, current
pregnancy or lactation, dentofacial deformity, major jaw trauma, previous TMJ surgery, or
previous steroid injection in the TMJ.

Table 1. Baseline clinical characteristics of the control and study groups with and without TMJ
dysfunction, according to Wilkes stage.
Subjects completed personal medical history questionnaires and, within a protocol approved
by an Institutional Review Board, signed a consent form after being advised of the nature of
the study. All patients were asked to complete a pain questionnaire, and a clinical examination
was performed according to Clinical Practice Guidelines for TMJ surgery of the American
Association of Oral Maxillofacial Surgeons. The patients were considered to be affected and
were treated surgically when presenting painful clinical signs of disc displacement after
unsuccessful nonsurgical treatment for at least six months.

Out of the eight control joints, five were condyle fractures (CFx), confirmed by radiographs and
CT scan; the patients had to undergo surgery for the fracture reduction. Three joints displayed
active condyle hyperplasia (CH), diagnosed by radiographs. All patients had a panorex; the
patients with condyle fracture had a CT scan, and most of the patients in the study group had
an MRI.
The sample was divided as follows:
(1) Joints without any signs of disc displacement (control group; n = 8 disc specimens);
(2) Joints presenting anterior disc displacement with reduction (ADDwR; n = 21 disc
specimens);
(3) Joints presenting anterior disc displacement without reduction (ADDwoR; n = 10 disc
specimens).
Joints were clinically categorized according to the presence or absence of disc displacement
and, secondarily, according to the presence or absence of osteoarthrosis (according to Wilkes
classification) [29].
Joints’ selection for osteoarthrosis analysis was based on the primary diagnosis of severe TMJ
internal derangement (ID). The stages of TMJ ID were classified into mild, intermediate, and
severe, according to Wilkes classification, based on clinical, surgical, and pathological stages
[29]. Mild ID (Wilkes stage III) is characterized by simple disc displacement without any
morphological alteration of the disc and with or without osseous shift. The intermediate stage
(Wilkes stage IV) is characterized by disc displacement and morphological deformity and/or
osseous remodeling changes. Severe derangement (Wilkes stage V) is characterized by
perforations of the disc attachments and osseous shift and/or osteoarthrosis changes
(sclerosis, osteophyte formation, articular surface flattening, depression and/or cystic
alterations) [29]. Joints from the control group and those classified as Wilkes III were considered
not presenting osteoarthrosis, and joints classified as Wilkes IV or V were included in the
osteoarthrosis group, as follows:
(1) Joints without osteoarthrosis (control group + Wilkes stage III; n = 29 disc
specimens);
(2) Joints with osteoarthrosis (Wilkes stage IV and V; n = 10 disc specimens).
Table 1 shows the baseline characteristics of the sample.
Surgical technique
TMJ surgery was performed by the same surgeon, according to the technique described by
Mehra and Wolford [30].
First, the displaced disc was freed by the surgeon entering the upper and lower joint spaces
and lysing adhesions. At this point, a small hole was placed through the lateral-posterior pole
of the condyle from a posterior to anterior direction. The Mitek bone-cleat introducer was

inserted and pushed into the bone, where two small coils unlocked and attached the cleat to
the inner surface of the condyle cortical bone. A non-resorbable 2–0 or 3–0 suture was placed
through the hole and through the disc at the junction of the posterior and intermediate bands,
and the disc was tied down to the condylar neck. The deformity of the disc precluded
repositioning it into the ideal position, and re-contouring the thickened disc with a scalpel was
necessary (this scalpelled material constitutes the specimen).
This procedure was conducted for all patients with disc displacement and the control group. In
the CFx patients, the disc displaced by fracture was repositioned, and in the CH patients, the
disc was sutured to prevent disc displacement caused by the gap that was created after the
high condylectomy. Postsurgical physical therapy was indicated at the discretion of the
surgeon.
Histological sections obtained by scalpel of disc excess were prepared for observation of the in
situ expression of MMP-13 by immunohistochemistry.

Immunohistochemistry
The TMJ disc sections were deparaffinized with xylol (2 × 10 min) and rehydrated with absolute
ethylic alcohol (3 × 1 min) and 80% ethylic alcohol (1 × 1 min). Endogenous peroxidase activity
was quenched by treatment with H2O2 (5% in methanol) for 10 min. Target Retrieval SolutionTM
(Dako, DK-2600 Glostrup, Denmark) was used prior to slide staining for heat-inducing epitope
retrieval (for formalin-fixed, paraffin-embedded material), according to the manufacturer’s
instructions. The sections were incubated with monoclonal MMP-13 antibody (Abcam PLC,
Cambridge, UK), diluted 1:50 in phosphate-buffered saline (PBS), 0.1% bovine serum albumin
(BSA). For negative controls, the primary antibody was not added. PBS was used instead. The
secondary antibody, AdvanceTM (Dako, DK-2600 Glostrup, Denmark), was applied for 30 min,
according to the manufacturer’s instruction.
The immunoreactions were visualized by incubating the sections using 3,3′ diaminobenzidine
(DAB) chromogen (OriGene, Rockville, MD, USA), (1 drop in 1 mL distilled water). The
sections were lightly counterstained with Harris haematoxylin for 5 min, and finally mounted.
Immunostaining was considered to be specific to MMP-13 because immunoreactivity was not
observed in the negative controls.
The color morphometry method was used to analyze the anti-MMP-13 immunostained area in
the TMJ disc tissue. For this purpose, images of consecutive fields were captured by a 20×
objective lens coupled with the BX50 Olympus microscope with a Sony camera, Model DXC107A, and image analysis was performed with specific software called Image Pro Plus
software (Media Cybernetics Inc., Rockville, MD, USA). This software allows an observer to
select and paint the positive areas to obtain an image model and make the mask for the other
stained slides, the area of the positive reaction being automatically calculated. This procedure
was performed by a single examiner in a blind manner. The data were entered into a
spreadsheet, and Microsoft Excel (Redmond, WA, USA) was used to obtain the statistical
analysis. The variable area was measured in square micrometers (μm2) and was obtained with
the mean of all positive areas.

Statistical analysis
To compare the groups (control, ADDwR and ADDwoR) regarding area, the non-parametric
Kruskal-Wallis analysis was considered. To compare groups with and without osteoarthrosis,
the non-parametric Mann-Whitney test was employed. To meet the symmetric condition of the
variable, data of area were previously submitted to a logarithmic transformation. The p
value <0.05 was considered statistically significant. Data were analyzed with IBM SPSS
Statistics v.20.0 software (IBM Corporation, Armonk, NY, USA).

Results
Expression of MMP-13 was observed at cytoplasm level.

Expression of MMP-13 in TMJ sample ADDwR, ADDwoR and control
Significant differences were not found in the expression of MMP-13 in TMJ discs between the
three groups for the variable area (p = 0.288) (Table 2).

Table 2. MMP-13 area of immunostaining (μm2) in the discs of the control and study groups
with and without TMJ dysfunction.

Expression of MMP-13 in TMJ discs of patients with and without
osteoarthrosis
All joints with ADDwoR presented osteoarthrosis. On the other hand, almost all joints without
osteoarthrosis presented ADDwR.
Statistically significant differences were not found in the expression of MMP-13 in TMJ discs
between the groups with and without osteoarthrosis for the variable area (p = 0.185) (Table 3).

Table 3. Differences between groups with and without osteoarthrosis, with respect to area of in
situ expression (μm2) of MMP-13 cytokine.

Discussion
In the last few years, the expression of matrix metalloproteases and some others markers,
such as Fas Ligand (FasL) and ADAM metallopeptidase domain 17 (ADAM-17), were shown in
the progression of TMJ ID using TMJ discs and synovial fluid [15–26].
The articular disc of the TMJ is formed by proteoglycan aggregates and collagen types 1 and
2. But the TMJ’s disc is a fibrocartilage, different from other joints in the body (hyaline
cartilage), and this disc is composed mostly of type 1 collagen rather than type 2, whereas
hyaline cartilage has no type 1 collagen [5,10,13]. A balance between degradation of collagen
fibers performed by matrix metalloproteinase (MMP) and their tissue inhibitor of
metalloproteinase (TIMP), are responsible for functional remodeling of the TMJ [21,26–28].
MMPs have been reported to be involved in the cleavage of cell surface receptors and the
release of apoptotic ligands (such as the Fas ligand). They play an important role in tissue
remodeling associated with various physiological or pathological processes such as
morphogenesis, angiogenesis, tissue repair, cirrhosis, arthritis, and metastasis [21,27,28].
Loreto et al. [21] showed that MMP-7 and MMP-9 are expressed in arthritic joints and provided
evidence of a role for those MMPs in TMJ ID disc damage, with higher expression being
detected in the posterior rather than in the anterior and intermediate bands of ADDwR and
ADDwoR discs.
Almeida et al. [24], in a study using MMP-2 and MMP-9, did not find a statistically significant
difference between the variable area of MMP-9 expression in the disc with or without disc
displacement, as determined by immunohistochemical analysis. However, an elevation of
MMP-2 expression in the discs of patients with ADDwoR (more severe alteration) was
identified.
One of the most important metalloproteinases involved in degradation of collagen within the
cartilage is MMP-13 (collagenase-3), a metalloproteinase of the collagenase group, which
performs preferential digestion of type 2 collagen over type 1 and 3 collagens [26–28]. Leonardi
et al. [26] found correlation of an increased MMP-13 immunoreactivity in TMJ diseased disc
tissue with the increased severity of the histopathological changes; however that study was
performed with cadavers’ discs.
In this study, the hypothesis is that MMP-13 may be involved in the progression of TMD, since
other studies have already demonstrated the correlation of MMPs with this progression.

Significant differences were not observed between the groups control and with or without
anterior disc reduction of the articular disc, with respect to the variable area for the expression
of MMP-13 measured by immunohistochemical examination. This lack of expression could be
due to the composition of the TMJ disc, which is mainly collagen type 1, and MMP-13 is less
effective at breaking down type 1 collagen than type 2 collagen.
Osteoarthrosis is characterized by deterioration and abrasion of articular cartilage. Some
papers have demonstrated the association of MMPs (MMP-7, MMP-9, MMP-13) with
osteoarthrosis, an inflammatory disorder of movable joints, in the degenerative process of
joints included in the TMJ [21,27,28].
Schlopov et al. [31] suggested a key role of MMP-13 and MMP-8, as well as MMP-1 in
osteoarthrosis.
This study has some limitations, such as the restrictive sample size; however this still seems to
be the biggest sample size so far in TMJ studies, to the authors’ knowledge. This reduced
number refers to the fact that only a low number of patients must be submitted to surgical
treatment.
In this study, significant differences between the groups with and without osteoarthrosis with
respect to the variable area for the expression of MMP-13 measured by immunohistochemical
examination were not observed.

Conclusion
In conclusion, the expression of MMP-13 was not associated with TMD and osteoarthrosis in
the study population.
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